Page last updated: 2024-08-21

podophyllotoxin and Acute Disease

podophyllotoxin has been researched along with Acute Disease in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	21 (53.85)	18.7374
1990's	13 (33.33)	18.2507
2000's	3 (7.69)	29.6817
2010's	2 (5.13)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, J; Chen, M; Liu, J; Sun, H; Wang, L; Xu, L; Yang, X; Zheng, M	1
Dünweber, A; Fridthjof, KS; Friis, LS; Gørløv, JS; Kampmann, P; Kjeldsen, L; Moser, C; Møller, T; Nexø, C; Nørskov, KH; Welinder, PC	1
Jaffrey, I; Pashaei, S; Ryder, J; Sun, T	1
Aparicio Urtasun, J; Díaz Beveridge, R	1
Hanada, S; Otsuka, M; Owatari, S; Takeshita, T; Uozumi, K	1
Dahl, GV; Look, AT; Mauer, AM; Rivera, G	1
Bowman, WP; Dahl, GV; Evans, WE; Kalwinsky, D; Look, AT; Rivera, G	1
Hunstein, W; Körbling, M	1
Arakawa, S; Esumi, N; Imashuku, S	1
Dubovsky, DW; Jacobs, P; Wood, L	1
Dubovsky, DW; Jacobs, P; Kernoff, LM	1
Cavalli, F; Sauter, C; Varini, M	1
Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vygovskaia, IaI	1
Crist, WM; Pui, CH; Rivera, GK	1
Behm, FG; Bowman, LC; Head, DR; Heaton, D; Hurwitz, CA; Pui, CH; Raimondi, SC; Sandoval, C	1
Murphy, SB	1
Cazenave, L; Gehan, E; Heyn, R; Khan, FM; Maurer, HM; Rubinstein, L; Smith, MA; Ungerleider, RS	1
Hancock, ML; Heslop, HE; Mahmoud, HH; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Rivera, GK; Sandlund, JT; Santana, VM	1
Anttila, VJ; Isomäki, HA; Kauppi, M; Savolainen, HA	1
Bowman, WP; Buchanan, GR; Friedman, DJ; Mustafa, MM; Sandler, ES; Winick, NJ	1
Karp, JE; Smith, MA	1
Geisler, C; Myhre, J; Pedersen, M; Pedersen-Bjergaard, J	1
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D	1
Comelli, A; Massimo, L	1
Bleyer, WA; Chard, RL; Hammond, D; Krivit, W	1
Dubovsky, D; Jacobs, P; Kernoff, L	1
Batz, K; Brunner, KW; Cavalli, F; Ryssel, HJ; Sonntag, RW	1
Donaldson, MH; Rosenstock, JG	1
Dubovsky, D; Jacobs, P	1
Ratain, MJ; Rowley, JD	1
Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT	1
Pui, CH	1
Cockerill, K; Culbert, S; Hester, J; Horwitz, L; Jagannath, S; Keating, M; Larry, N; Spitzer, G; Vellekoop, L; Zander, AR	1
Chan, HY; Lewis, JP; Meyers, FJ	1
Abe, T; Kariyone, S; Maekawa, I; Maekawa, T; Miura, A; Miura, Y; Moriyama, Y; Shibata, A; Wakui, A; Yoshida, Y	1
Gomis, F; Lorenzo, I; Martín-Aragonés, G; Martínez, JA; Marty, ML; Rafecas, FJ; Sanz, G; Sanz, MA	1
Jacobs, P	1
Kimura, K; Yamada, K; Yoshida, T	1
Arakawa, S; Esumi, N; Imashuku, S; Todo, S	1

Reviews

4 review(s) available for podophyllotoxin and Acute Disease

Article	Year
[Therapy-related acute leukaemia and myelodysplastic syndrome]. Anales de medicina interna (Madrid, Spain : 1984), 2003, Volume: 20, Issue:5 Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Palliative Care; Podophyllotoxin; Prognosis	2003
In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy. Blut, 1984, Volume: 48, Issue:4 Topics: Acute Disease; Animals; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Leukemia; Lymphoma; Mechlorethamine; Neoplastic Stem Cells; Photosensitivity Disorders; Podophyllotoxin; Pyrimidinones; Rats; Transplantation, Autologous	1984
The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention. Seminars in oncology, 1997, Volume: 24, Issue:1 Topics: Acute Disease; Antineoplastic Agents, Alkylating; DNA Damage; DNA Repair; Humans; Leukemia, Myeloid; Molecular Epidemiology; Neoplasms, Second Primary; Podophyllotoxin	1997
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:2 Topics: Acute Disease; Antineoplastic Agents; DNA Damage; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Topoisomerase II Inhibitors	1992

Trials

6 trial(s) available for podophyllotoxin and Acute Disease

Article	Year
In adult acute nonlymphoblastic leukaemia extended maintenance chemotherapy has no benefit. American journal of hematology, 1984, Volume: 16, Issue:3 Topics: Acute Disease; Adolescent; Adult; Cytarabine; Doxorubicin; Humans; Leukemia; Middle Aged; Podophyllotoxin; Prognosis	1984
High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia, 1997, Volume: 11, Issue:10 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Risk Factors	1997
Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group. Cancer treatment reports, 1979, Volume: 63, Issue:6 Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Child; Clinical Trials as Topic; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Neoplasms; Neuroblastoma; Podophyllotoxin; Remission, Spontaneous; Teniposide	1979
Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia. Cancer treatment reports, 1976, Volume: 60, Issue:3 Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Evaluation; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Podophyllotoxin; Teniposide	1976
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. The New England journal of medicine, 1991, Dec-12, Volume: 325, Issue:24 Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide	1991
The epipodophyllotoxin VP16-213 in combination chemotherapy for adults with acute nonlymphoblastic leukaemia. Haematology and blood transfusion, 1985, Volume: 29 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Doxorubicin; Etoposide; Humans; Leukemia; Podophyllotoxin; Thioguanine	1985

Other Studies

29 other study(ies) available for podophyllotoxin and Acute Disease

Article	Year
miR-483-3p regulates acute myocardial infarction by transcriptionally repressing insulin growth factor 1 expression. Molecular medicine reports, 2018, Volume: 17, Issue:3 Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Enzyme-Linked Immunosorbent Assay; Female; Humans; Insulin-Like Growth Factor I; Male; MicroRNAs; Myocardial Infarction; Podophyllotoxin; Proto-Oncogene Proteins c-bcl-2; Rats	2018
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma. British journal of haematology, 2018, Volume: 181, Issue:5 Topics: Acute Disease; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Humans; Infusion Pumps; Leukemia; Lymphoma; Male; Melphalan; Middle Aged; Outpatients; Podophyllotoxin	2018
A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia. Human pathology, 2003, Volume: 34, Issue:5 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; CD2 Antigens; Cytarabine; Flow Cytometry; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Lymphoid; Male; Melphalan; Podophyllotoxin	2003
Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma. International journal of hematology, 2007, Volume: 85, Issue:1 Topics: Acute Disease; Alkylating Agents; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin	2007
Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia. Cancer chemotherapy and pharmacology, 1982, Volume: 7, Issue:2-3 Topics: Acute Disease; Adolescent; Adult; Azacitidine; Cell Division; Child; Child, Preschool; DNA, Neoplasm; Drug Resistance; Etoposide; Female; Flow Cytometry; Humans; Infant; Kinetics; Leukemia; Male; Mitosis; Podophyllotoxin	1982
Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood. Cancer treatment reviews, 1982, Volume: 9 Suppl Topics: Acute Disease; Azacitidine; Child; Drug Therapy, Combination; Etoposide; Humans; Leukemia; Podophyllotoxin; Prednisone; Vincristine	1982
[VP 16-213 in the treatment of acute leukemia in childhood]. Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:3 Topics: Acute Disease; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Podophyllotoxin	1983
The University of Cape Town leukaemia centre: the first 5 years. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Mar-15, Volume: 57, Issue:11 Topics: Academic Medical Centers; Acute Disease; Bone Marrow Transplantation; Cytarabine; Doxorubicin; Drug Therapy, Combination; Humans; Leukapheresis; Leukemia; Podophyllotoxin; South Africa; Transplantation, Homologous	1980
Etoposide in the treatment of acute leukemia in adults. Cancer treatment reviews, 1982, Volume: 9 Suppl Topics: Acute Disease; Adult; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Humans; Leukemia; Podophyllotoxin	1982
[Use of VM 26 (epipodophyllotoxin) in treating acute leukemias and lymphomas in the adult]. Problemy gematologii i perelivaniia krovi, 1981, Volume: 26, Issue:7 Topics: Acute Disease; Adult; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lymphoma; Podophyllotoxin; Teniposide; Time Factors	1981
The epipodophyllotoxins: both sides of the coin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:8 Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1993
Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:6 Topics: Acute Disease; Adolescent; Alkylating Agents; Antineoplastic Agents; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Intercalating Agents; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Radiotherapy; Topoisomerase II Inhibitors; Translocation, Genetic	1993
Secondary acute myeloid leukemia following treatment with epipodophyllotoxins. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:2 Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Failure	1993
Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins. Journal of the National Cancer Institute, 1993, Apr-07, Volume: 85, Issue:7 Topics: Acute Disease; Adult; Child; Clinical Trials as Topic; Etoposide; Humans; Incidence; Leukemia, Myeloid; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin	1993
Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia, 1995, Volume: 9, Issue:12 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Podophyllotoxin	1995
Leukaemia during podophyllotoxin treatment in a patient with juvenile chronic arthritis. Scandinavian journal of rheumatology, 1996, Volume: 25, Issue:5 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Glycosides; Humans; Leukemia; Lignans; Neoplasms, Second Primary; Podophyllotoxin	1996
Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia. Cancer, 1997, Mar-01, Volume: 79, Issue:5 Topics: Acute Disease; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Survival Analysis	1997
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. British journal of cancer, 1999, Volume: 81, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine	1999
[New drugs for the therapy of acute leukemia]. Minerva medica, 1975, Jul-28, Volume: 66, Issue:52 Topics: Acute Disease; Antineoplastic Agents; Azacitidine; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Guanazole; Humans; Leukemia; Lomustine; Peptichemio; Podophyllotoxin; Razoxane; Zinostatin	1975
Rapid remission induction in adult acute non-lymphoblastic leukaemia. European journal of cancer, 1978, Volume: 14, Issue:11 Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous; Sepsis; Time Factors	1978
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia]. Schweizerische medizinische Wochenschrift, 1975, Feb-22, Volume: 105, Issue:8 Topics: Acute Disease; Adolescent; Adult; Aged; Chemical Phenomena; Chemistry; Chronic Disease; Drug Evaluation; Female; Glucosides; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous	1975
Letter: Treatment of acute leukaemia. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1975, Nov-01, Volume: 49, Issue:46 Topics: Acute Disease; Cytarabine; Doxorubicin; Drug Therapy, Combination; Humans; Leukemia; Methotrexate; Podophyllotoxin	1975
Therapy-related myeloid leukaemia. Lancet (London, England), 1990, Nov-03, Volume: 336, Issue:8723 Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors	1990
High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia. Cancer, 1987, Mar-15, Volume: 59, Issue:6 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Humans; Leukemia; Podophyllotoxin	1987
High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia. Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:3 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Female; Humans; Leukemia; Liver; Male; Middle Aged; Podophyllotoxin; Recurrence; Time Factors	1987
[A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1985, Volume: 26, Issue:11 Topics: Acute Disease; Adolescent; Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Leukemia; Lymphoma; Male; Middle Aged; Podophyllotoxin	1985
[Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase]. Sangre, 1985, Volume: 30, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Podophyllotoxin	1985
[Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1 Topics: Acute Disease; Adolescent; Adult; Aged; Alopecia; Anorexia; Drug Evaluation; Etoposide; Fatigue; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nausea; Podophyllotoxin	1986
[Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia; Lymphoma; Male; Myeloproliferative Disorders; Podophyllotoxin	1986